Life Sciences Archive » September, 2007

Life Sciences - September, 2007

158 articles

• Clinical Trial Patients Barely Protected By FDA: Study
• Canada Upholds Viagra Patent Over Apotex' Protests
• Immucor Lays SEC, Shareholder Actions To Rest
• BMS, Apothecon Pay $515M To Settle Pricing Claims
• DOJ Fights Veterans' Health Care Reform Suit
• Planned Parenthood Stole Business Method: Suit
• Kraft Renews Battle Cry For Stay In P&G Feud
• Q&A With Faegre & Benson's Ken Liebman
• Asbestos Victims Want Quigley President Out
• FDA Orders Halt To Unapproved Cough-Suppressants
• Microsoft Ruling May Embolden Regulators: Experts
• Suit Against Isolagen, Underwriters Moves Forward
• Orthopedic Cos. Pay $311M To End Kickback Probe
• Teva, Barr Win Transfer Of Aventis' Allegra Patent Suit
• President Bush Signs Drug User Fee Bill
• Medtronic Vows To Appeal $226.3M Verdict
• Court Knocks Digene Down Again In HPV Suit
• Adams Respiratory Sues Perrigo Over Mucinex Patent
• PTO Erred In Nixing Takeda's Double-Patent: Judge
• Appeals Court Overturns $58M Ruling Against Vonage
• No Federal Jurisdiction For Zyprexa Suit: Montana
• Damages Back In Play In Pfizer Patent Suit
• FDA Warns Consumers About Pain Drug
• Punitive Damages Nixed In Accutane Suicide Case
• Drug Makers Prevail In Hormone Replacement Suit
• Pharmacogenomics And The "Learned Intermediary"
• P&G Fights Kraft's Stay Bid In Coffee Packaging Spat
• Judge Hands Alaris More Money In Patent Suit
• AstraZeneca Asks For More Discovery Time
• Novartis Accused Of Forum Shopping In Lamisil Case
• Dietary Supplement Maker's Antitrust Suit Tossed
• Supreme Court Agrees To Hear Rezulin Case
• Utah AG Sues Slew Of Drug Cos. Over AWPs
• Roche Fights To Protect Boniva Patent
• Depomed Says Teva Unit Infringed Diabetes Patents
• Supreme Court To Tackle Patent Exhaustion
• Becton Dickinson Balks At Discovery In Syringe MDL
• Eli Lilly Pays $18M To Settle Contract Squabble
• AstraZeneca Wants Seroquel, Zyprexa Plaintiffs' Docs
• Barr Sued Over Chewable Contraceptive
• Cordis Cites Stent Risk But Still Loses Patent Fight
• Dr. Reddy's Wants Clarinex Claims Trimmed
• Dutch Pension Fund Files Amended Suit Over Vioxx
• Guidant Fights Health-Care Providers' Appeal Attempt
• Hogan & Hartson LLP
• House Bill Would Strengthen Food Import Laws
• FDA Defends Delays Over Vioxx Documents
• Pfizer Wins Appeal Over Neurontin
• AWP Counsel Asks Court To Kick Haviland Law Firm
• Alza Makes Another Push For Data In Ditropan Case
• Environmental Guns Take Shot At Air Fresheners
• Accutane Trial To Begin Monday, As Planned
• Novartis Drops Patent Claims Against Ranbaxy
• Cadwalader Forms New IP Group
• Red Cross Fights Off J&J Suit Over Famous Mark
• House Approves FDA Drug User Fee Legislation
• Actavis Claims Cancer Drug Patents Are Invalid
• Epstein Becker
• Kraft Seeks Stay In P&G Coffee Packaging Spat
• FDA Updates Warning Labels On Blockbuster Drugs
• Biotech Expert Becomes Dechert IP Partner
• Software Co. Sues Fanuc, GE Over Robot Patents
• Judge Greenlights Baycol Plaintiffs' Appeal
• Orexigen, Duke, Eisai Strike Foreign IP Deal
• Applera, Agilent Settle Genetic Research Patent Spat
• Defibrillators Could Fail, Recall Warns
• FDA Claims Dirty Advertising Over P&G Sanitizer
• Bio-Rad Claims Infringment Of Microplate Patent
• Bayer Seeks Stay In Tainted Blood Products Suit
• Encysive Wins Dismissal Of Securities Suit
• Cordis Stent Case May Be Consolidated
• Abbott Shoots Down Government Complaint
• ICU Medical Prevails In IV Patent Dispute
• Aredia Case Belongs In State Court: Magistrate Judge
• New York Hits Merck With Another Vioxx Suit
• J&J, Angiotech Reach Accord Over Stent Patents
• Roche Files Third Suit This Month Over Boniva ANDAs
• Pfizer Moves To Toss More Cases From Bextra MDL
• J&J Asks Court To Resurrect Claim Against Abbott
• Apotex Bid To Overturn Prilosec Decision Denied
• Certified Ortho-McNeil FLSA Class Expected To Swell
• Merck Balks At Class Bid In Fosamax Case
• Judge Nixes Glaxo's Bid To Strike Paxil Testimony
• 211 Plaintiffs Will Join Suit Against Merck Over FLSA
• Improper Use Of Fentora Can Be Deadly: Cephalon VP
• Judge Rejects Lipodissolve Ban
• Orion sues Wockhardt Over Parkinson's Drug
• Foley Hoag
• NuvaRing Plaintiffs Battle Organon Over Jurisdiction
• Aventis To Face Whistleblower Claims Over Lovenox
• Sanofi Plaintiffs Challenge Employee Declarations
• Plaintiffs Deny Desire For Seal In Aredia Case
• ASC Resists Alza's Bid For Ditropan Data
• Judge Sends Two AWP Cases Home
• Before Settling, Guidant Plaintiffs Consider Appeal
• CORRECTED: Judge Issues Ruling In Guidant Price Publishing Spat
• O'Melveny & Myers
• Judge Upholds BofA Victory In Patent Suit
• Sans Injunction, Open Season For Generic Protonix
• AstraZeneca Backs Up Call To Toss Seroquel Claims
• Canadian Court Upholds Lipitor In Crystal Form
• Big Pharmas Cite Elevator Ruling To Boost Case
• Airborne Suit Moved To Federal Court
• Two New Articles Add More Fuel To Avandia Fire
• Hogan & Hartson Lures FDA Attorney
• Teva, Dr. Reddy's Settle Generic Zoloft Dispute
• Judge Tosses Some Claims In Merck Race Bias Suit
• Pfizer Faces Swelling MDL Over Bextra, Celebrex
• Novo Nordisk Seeks To Halt Sanofi Insulin Pen
• Apotex Suffers Defeat In Acular Dispute
• McKool Smith Opens ITC-Focused D.C. Office
• AstraZeneca, Plaintiffs Spar Over Seroquel Expert
• Ramipril Patent Invalid Due To Obviousness: Court
• Judge Mulls Plaintiffs' Bid To Alter Mirapex Suit
• Hoffman-La Roche Sues Teva Over Osteoporosis Drug
• Biovail Settles With BofA, Trader In Conspiracy Case
• Abbott, Feds Sound Off On AWP Ruling
• Sanofi-Aventis Pays $190M To Settle Drug Price Case
• ImClone To Pay $65M To End Erbitux Suit
• Abbott Fights Depositions Of Former Head Honchos
• Judge Blocks Sale Of Teva's Generic Famvir
• Faegre & Benson
• Judge OKs Settlement In Drug Securities Case
• Becton, RTI Spar Over Syringe Patents, Competition
• Pfizer Seeks Dismissal Of Another Bextra Suit
• Glaxo Investors Vie For Lead Plaintiff Role
• Abbott Warns Of Faulty Glucose Monitors
• Acacia Unit Targets Medical Tech Bigwigs
• Supreme Changes in Patent Law
• Judge Orders Plaintiffs To Respond In Accutane Case
• Seroquel Plaintiffs Object To Dismissal Conversions
• Eli Lilly Settles With Doctor Over Zyprexa Leaks
• Eli Lilly Adds 9 Defendants To Strattera Suit
• House Ushers In New Era With Patent Reform Act
• Sanctions Urged In Celexa, Lexapro Case
• Judge Orders Vioxx Plaintffs To File Separate Claims
• Nationwide Class For Vioxx Suit Rejected
• Par Calls Novartis' Lotrel Patent Unenforceable
• Judge OKs Insider Trading Settlement In Drug Case
• J&J Unit Wants ASC To Turn Over Ditropan Docs
• Enzo Appeals Loss In DNA Detection Patent Suit
• Novartis Rebuffs Claims In Aredia Case
• Glaxo Seeks To Bar Testimony In Paxil Case
• Judge Allows Teva To Launch Generic Herpes Drug
• Lexapro Patent Upheld On Appeal
• Ortho-McNeil Spars With Makers Of Ultracet Generic
• Greenberg Traurig Lures GlaxoSmithKline VP
• Pfizer Moves To Toss Fraud Claims In Mirapex Case
• Schering, Employees To Face Off Over Benefit Plan
• Switching Cholesterol Drugs May Be Fatal: Study
• Ninth Circuit Remands Royalty Dispute Over Zilactin
• AstraZeneca Seeks More Dismissals In Seroquel Case
• Dr. Reddy's Wants Teva's Coreg Claims Bounced
• Novartis Motion Is Wolf In Sheep's Clothing: Plaintiffs
• Reed Smith
• Allergan Sued Over Dry Eye Patent
• Pharmexa Loses Bid To Restore Broad Patent Claims
• Judge Siphons Off Funds For Aredia Attorneys